FDA Approved: SORAFENIB TOSYLATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA granted a supplemental approval for sorafenib tosylate (generic sorafenib) by Mylan Pharmaceuticals Inc., allowing the generic product to be marketed. The i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)

Snippet

SUPPL AP for SORAFENIB TOSYLATE (SORAFENIB)